NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-235-1993-0-PT-15 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY PT EP 95900491.2 Abandoned
NCI E-235-1993-0-ES-06 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY ES EP 95900491.2 Abandoned
NCI E-235-1993-0-SE-08 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY SE EP 95900491.2 Abandoned
NCI E-235-1993-0-CH-05 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY CH EP 95900491.2 Abandoned
NCI E-235-1993-0-GB-22 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY GB EP 95900491.2 Abandoned
NCI E-235-1993-0-DE-20 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY DE EP 95900491.2 Abandoned
NCI E-235-1993-0-GR-16 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY GR EP 3034099 Abandoned
NCI E-235-1993-0-FR-17 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY FR EP 95900491.2 Abandoned
NCI E-235-1993-0-AU-18 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY AU National Stage 81300/94 Abandoned
NCI E-235-1993-0-PCT-02 No_Patent_Title PCT PCT PCT/US94/12510 Abandoned
NCI E-235-1993-0-JP-23 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY JP National Stage 513345/1995 Abandoned
NHLBI E-156-1992-0-US-05 EXPRESSION OF HUMAN MULTIDRUG RESISTANCE GENES AND SELECTION OF CELLS TRANSDUCED WITH SUCH GENES US FWC 08/332,444 Abandoned
NCI E-235-1993-0-CA-19 NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY CA National Stage 2175467 Abandoned
NCI E-147-1991-2-US-01 CHIMERIC AND MUTATIONALLY STABILIZED TUMOR-SPECIFIC ANTIBODY FRAGMENT FUSION PROTEINS, AND USES THEREOF US CIP 08/331,397 5981726 Abandoned PDF
NCI E-147-1991-1-US-01 HUMANIZED TUMOR-SPECIFIC ANTIBODY FRAGMENTS, FUSION PROTEINS, AND USES THEREOF US CIP 08/331,396 5889157 Abandoned PDF
NCI E-147-1991-3-US-01 SINGLE CHAIN B3 ANTIBODY FUSION PROTEINS AND THEIR USES US CIP 08/331,398 5608039 Abandoned PDF
NCI E-208-1992-0-CA-04 DEVELOPMENT OF A VECTOR TO TARGET GENE EXPRESSION TO THE EPIDERMIS OF TRANSCENIC ANIMALS CA National Stage 2134675 Abandoned
NCI E-132-1988-0-US-05 Use of 8-C1-cAMP as Anticancer Drug US FWC 08/329,764 5792752 Abandoned PDF
NCI E-151-2007-0-FR-01 Nucleotide Sequences Of HIV-1 Type (or Subtype) O Retrovirus Antigens FR ORD 94/12554 Expired
NIAID E-123-1992-3-US-01 ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE COMPOSITIONS US CIP 08/327,263 5922326 Expired PDF
NCI E-146-1992-0-US-23 USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY US FWC 08/330,865 6040334 Expired PDF
NIAID E-123-1992-2-NZ-10 ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE COMPOSITIONS NZ National Stage 252857 Expired
NHLBI E-151-1993-0-US-02 TARGETABLE VECTOR PARTICLES US FWC 08/326,347 Abandoned
NHLBI E-152-1993-0-US-07 VECTOR PARTICLES RESISTANT TO INACTIVATION BY HUMAN SERUM US FWC 08/326,348 Abandoned
NCI E-029-1990-1-US-02 HEPATOCELLULAR CARCINOMA ONCOGENE US FWC 08/324,445 5811262 Abandoned PDF
NINDS E-018-1995-0-US-01 METHOD OF MAKING PERCUTANEOUS CONNECOTR FOR MULT-CONDUCTOR ELECTRICAL CABLES US ORD 08/326,291 5604976 Abandoned PDF
NICHD E-177-1990-3-US-01 NEUROTROPHIC PEPTIDES OF ACTIVITY DEPENDENT NEUROTROPHIC FACTOR (as filed) US CIP 08/324,297 6174862 Expired PDF
NINDS E-530-1986-1-US-06 IMMUNOTOXINS - MUTANT DIPHTHERIA TOXIN CONJUGATES US CON 08/323,591 5792458 Expired PDF
NICHD E-202-1994-0-US-01 Synthesis of a Typhoid Fever Vaccine From a Plant or a Fruit Polysaccharide US ORD 08/323,918 5738855 Expired PDF
NIAID E-072-1993-0-US-03 CLONING AND EXPRESSION OF PLASMODIUM FALCIPARUM TRANSMISSION-BLOCKING TARGET ANTIGEN, PFS230 US FWC 08/323,170 5733772 Abandoned PDF
NHLBI E-143-1993-0-PCT-02 EFFICIENT AND SELECTIVE ADENOVIRAL-MEDIATED GENE TRANSFER INTO VASCULAR NEOINTIMA PCT PCT PCT/US94/011676 Expired
NIAID E-220-1989-2-US-03 PRODUCTION OF ISOLATED PROTEINACEOUS MATERIALS USING RECOMBINANT AVIPOX VIRUS VECTORS US CON 08/322,358 Abandoned
NCI E-221-1993-3-ES-38 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders ES EP 04030912.2 Abandoned
NCI E-221-1993-3-SE-60 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders SE EP 04030912.2 Abandoned
NCI E-221-1993-3-PT-57 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders PT EP 04030912.2 Abandoned
NCI E-221-1993-3-SK-62 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders SK EP 04030912.2 Abandoned
NCI E-221-1993-3-RS-59 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders RS EP 04030912.2 Abandoned
NCI E-221-1993-3-PL-56 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders PL EP 04030912.2 Abandoned
NCI E-221-1993-3-SI-61 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders SI EP 04030912.2 Abandoned
NCI E-221-1993-3-MK-53 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders MK EP 04030912.2 Abandoned
NCI E-221-1993-3-RO-58 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders RO EP 04030912.2 Abandoned
NCI E-221-1993-3-LU-50 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders LU EP 04030912.2 Abandoned
NCI E-221-1993-3-LI-48 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders LI EP 04030912.2 Abandoned
NCI E-221-1993-3-MC-52 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders MC EP 04030912.2 Abandoned
NCI E-221-1993-3-MT-54 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders MT EP 04030912.2 Abandoned
NCI E-221-1993-3-NL-55 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders NL EP 04030912.2 Abandoned
NCI E-221-1993-3-LV-51 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders LV EP 04030912.2 Abandoned
NCI E-221-1993-3-LT-49 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders LT EP 04030912.2 Abandoned
NCI E-221-1993-3-DE-35 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders DE EP 04030912.2 Abandoned
NCI E-221-1993-3-FR-40 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders FR EP 04030912.2 Abandoned